BioCryst Pharma (BCRX) – Management Comments
-
BioCryst Pharma (BCRX) Reports Prelim FY22 ORLADEYO Sales
-
BioCryst Pharma (BCRX) Adds $350 Million in New Financing with Royalty Pharma (RPRX) and OMERS Capital Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BCRX Stock Lookup